Genetic complementation to non-tumorigenicity in cervical-carcinoma cells correlates with alterations in AP-1 composition

Int J Cancer. 2000 Jun 15;86(6):811-7. doi: 10.1002/(sici)1097-0215(20000615)86:6<811::aid-ijc9>3.0.co;2-j.

Abstract

The transcription factor AP-1 represents a central key element in the expression of human pathogenic papillomaviruses (HPV). We here propose a novel role for AP-1 as an essential component of an intracellular surveillance mechanism negatively controlling the proliferation of HPV-positive cells under in vivo conditions. The dissection of AP-1 composition in cervical-carcinoma cells revealed an inverse relationship between the Fos-related antigen Fra-1 and the tumorigenic phenotype. Cervical-carcinoma cell lines were either negative or expressed only low amounts of Fra-1 (jointly with c-Fos) within their AP-1 complexes. Somatic-cell hybridization technique was used to fuse different HPV-positive malignant cell lines. This resulted either in tumorigenic hybrids or in cells in which the malignant phenotype of the parental fusion partners was completely suppressed. The monitoring of AP-1 composition in electrophoretic mobility super-shift assays showed that the amount of Fra-1 was substantially increased within the AP-1 complex of non-malignant cells. In contrast, Fra-1 was even diminished in malignant hybrids, while c-Fos remained expressed. This correlation suggests that the concentration of Fra-1 within the AP-1 transcription complex might be an important marker for predicting the in vivo growth properties of HPV-positive cells.

MeSH terms

  • Female
  • Genetic Complementation Test
  • Humans
  • Papillomaviridae / isolation & purification*
  • Proto-Oncogene Proteins c-fos / analysis
  • Transcription Factor AP-1 / analysis*
  • Tumor Cells, Cultured
  • Uterine Cervical Neoplasms / etiology*
  • Uterine Cervical Neoplasms / virology

Substances

  • Proto-Oncogene Proteins c-fos
  • Transcription Factor AP-1
  • fos-related antigen 1